The trajectory of companies tied to the drug's past presents a challenging investment landscape. While the initial boom generated substantial profits , generic competition have significantly impacted revenue. https://alphabookmarking.com/story21485773/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-investment